CDEK
← All drugs Report issue

cd20 car-t cells

Cell therapyexperimental

Clinical trial activity

18 trials · 19 clinical orgs · 0 marketing orgs

Phase 1
16
Phase 2
7
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2013 (NCT01735604)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • anti-cd20-car t cells
  • anti-cd20-car-t cells
  • cd20 car-t cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06519344Early Phase 1 (Phase 1)Jul 31, 2024Huazhong University of Science and Technology
NCT06508775N/AMay 5, 2024Miltenyi Biotec, Inc., University of Munster
NCT06313957Phase 1Mar 14, 2024Beijing Boren Hospital, GenScript, Peking University
NCT06532643Early Phase 1 (Phase 1)Aug 24, 2023Anhui Medical University, Government of China
NCT05149391Phase 1Jul 20, 2021Chinese Academy of Medical Sciences, Peking University
NCT04723914Phase 1/Phase 2 (Phase 2)Oct 20, 2020Shenzhen University
NCT04160195Phase 1Dec 6, 2019National Cancer Institute (NCI)
NCT04169932Early Phase 1 (Phase 1)Nov 22, 2019Shanghai Longyao Biotechnology Inc., Ltd.
NCT04176913Phase 1Nov 20, 2019Nanjing Medical University
NCT04036019Phase 1May 13, 2019Cellular Biomedicine Group Ltd., Huazhong University of Science and Technology
NCT03893019Early Phase 1 (Phase 1)Mar 8, 2019DLR German Aerospace Center, Miltenyi Biotec, Inc., University of Cologne
NCT03664635Phase 1/Phase 2 (Phase 2)Sep 10, 2018Miltenyi Biotec, Inc.
NCT03576807Phase 1Apr 4, 2018Shanghai Longyao Biotechnology Inc., Ltd.
NCT03207178Phase 1/Phase 2 (Phase 2)Mar 1, 2017Jiao Tong University, Shanghai Longyao Biotechnology Inc., Ltd., Xuzhou Medical University
NCT02846584Phase 2Jul 1, 2016People's Liberation Army of China
NCT02737085Phase 1/Phase 2 (Phase 2)Mar 1, 2016People's Liberation Army of China
NCT02710149Phase 1/Phase 2 (Phase 2)Mar 1, 2016People's Liberation Army of China
NCT01735604Phase 1/Phase 2 (Phase 2)Jan 1, 2013People's Liberation Army of China
Showing 18 of 18 trials
Page 1 / 1

Organizations

Research & Development (19)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
People's Liberation Army of ChinaGovernment4412013
Miltenyi Biotec, Inc.For profit3332018
Shanghai Longyao Biotechnology Inc., Ltd.Government3322017
Huazhong University of Science and TechnologyAcademic/Hospital2212019
Peking UniversityAcademic/Hospital2212021
Anhui Medical UniversityAcademic/Hospital1012023
Beijing Boren HospitalAcademic/Hospital1012024
Cellular Biomedicine Group Ltd.For profit1012019
Chinese Academy of Medical SciencesAcademic/Hospital1012021
DLR German Aerospace CenterAcademic/Hospital1012019
GenScriptFor profit1012024
Government of ChinaGovernment1112023
Jiao Tong UniversityAcademic/Hospital1012017
Nanjing Medical UniversityAcademic/Hospital1112019
National Cancer Institute (NCI)Government1112019
Shenzhen UniversityAcademic/Hospital1112020
University of CologneAcademic/Hospital1012019
University of MunsterAcademic/Hospital1012024
Xuzhou Medical UniversityAcademic/Hospital1012017
19 organizations
Page 1 / 1